GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Vystar Corp (OTCPK:VYST) » Definitions » Net Current Asset Value

VYST (Vystar) Net Current Asset Value : $-0.34 (As of Mar. 2025)


View and export this data going back to 2009. Start your Free Trial

What is Vystar Net Current Asset Value?

In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).

Vystar's net current asset value per share for the quarter that ended in Mar. 2025 was $-0.34.

The historical rank and industry rank for Vystar's Net Current Asset Value or its related term are showing as below:

VYST's Price-to-Net-Current-Asset-Value is not ranked *
in the Chemicals industry.
Industry Median: 5.04
* Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.

Vystar Net Current Asset Value Historical Data

The historical data trend for Vystar's Net Current Asset Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vystar Net Current Asset Value Chart

Vystar Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Current Asset Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.82 -1.48 -0.76 -0.58 -0.31

Vystar Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Net Current Asset Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.59 -0.61 -0.63 -0.31 -0.34

Competitive Comparison of Vystar's Net Current Asset Value

For the Specialty Chemicals subindustry, Vystar's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vystar's Price-to-Net-Current-Asset-Value Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Vystar's Price-to-Net-Current-Asset-Value distribution charts can be found below:

* The bar in red indicates where Vystar's Price-to-Net-Current-Asset-Value falls into.


;
;

Vystar Net Current Asset Value Calculation

Vystar's Net Current Asset Value (NCAV) per share for the fiscal year that ended in Dec. 2024 is calculated as

Net Current Asset Value Per Share(A: Dec. 2024 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(0.407-5.84--0.03-0)/17.401
=-0.31

Vystar's Net Current Asset Value (NCAV) per share for the quarter that ended in Mar. 2025 is calculated as

Net Current Asset Value Per Share(Q: Mar. 2025 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(0.423-6.375--0.03-0)/17.401
=-0.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vystar  (OTCPK:VYST) Net Current Asset Value Explanation

Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."

The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]

Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham’s strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.


Vystar Net Current Asset Value Related Terms

Thank you for viewing the detailed overview of Vystar's Net Current Asset Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Vystar Business Description

Traded in Other Exchanges
N/A
Address
365 Shrewsbury Street, Worcester, MA, USA, 01604
Vystar Corp is engaged in the rubber and plastic products market. It develops technology to produce Vytex Natural Rubber Latex which reduces antigenic protein and non-rubbers in natural rubber latex to undetectable levels. The company's products and services include Natural Rubber Latex and clinical sleep diagnostics and durable medical equipment. The company derives revenue from sales of or license fees of Vytex NRL raw material to manufacturers and distributors of rubber and rubber end products.
Executives
Byron Lee Novosad other: Board Member 14019 SW FREEWAY, # 301 PMB 181, SUGAR LAND TX 77478
Bryan Lawrence Stone director C/O VYSTAR CORPORATION, 101 AYLESBURY RD., WORCESTER MA 01609
Keith D. Osborn 10 percent owner 5671 PEACHTREE-DUNWOODY RD., ATLANTA GA 30342
Paul R. Oristaglio director 955 COUNTY ROAD, BARRINGTON RI 02806
Steven Rotman director, officer: Chief Executive Officer C/O VYSTAR CORPORATION, 101 AYLESBURY RD., WORCESTER MA 01609
Joseph Carmen Allegra director C/O VYSTAR CORPORATION, 101 AYLESBURY RD., WORCESTER MA 01609
William R. Doyle director, officer: Chairman, President & CEO VYSTAR CORPORATION, 3235 SATELLITE BLVD, BUILDING 400, SUITE 290, DULUTH GA 30096
Joseph Allegra director VYSTAR CORPORATION, 3235 SATELLITE BLVD., BUILDING 400, SUITE 290, DULUTH GA 30096
Jason M. Meggs director C/O SYNEOS HEALTH, INC., 1030 SYNC STREET, MORRISVILLE NC 27560
Ranjit K. Matthan director C/O VYSTAR CORPORATION, 2484 BRIARCLIFF RD NE, SUITE 159, ATLANTA GA 30329
Mangum Michelle (mitsy) Y. director VYSTAR CORPORATION, 3235 SATELLITE BLVD, BUILDING 400, SUITE 290, DULUTH GA 30096
Michael X Ianacone director C/O VYSTAR CORPORATION, 2484 BRIARCLIFF RD NE, SUITE 159, ATLANTA GA 30329
Thomas L Mills director C/O WINSTON & STRAWN,, 1400 L. STREET, N.W, WASHINGTON DC 20005
Paul A. Yeoham director C/O VYSTAR CORP., 3235 SATELLITE BLVD., BUILDING 400, SUITE 290, DULUTH GA 30096
Dale Thomas Marsh director C/O VYSTAR CORPORATION, 3235 SATELLITE BLVD., BLDG. 400, STE 290, DULUTH GA 30096